Details
- Organisation Name: Mackay Base Hospital
- HHS: Mackay
- Services Offered: Clinical trials site; Investigator Initiated Trials; Satellite Site; Trial Patient Recruitment; Treatment of patients; Completion of study documentation as per ICH GCP and contract
- Website Address: www.mackay.health.qld.gov.au/your-hospitals/mackay-base-hospital/
- Contact: Clinical Trials Unit – [email protected]
- Other Affiliated Research Sites: Royal Brisbane and Women's Hospital; Princess Alexandra Hospital; Rockhampton Hospital; Toowoomba Hospital; Townsville Hospital and Cairns Hospital.
Location
-21.14571 - 149.15609
Initiating study activities approval
No
Review required
2 weeks
Site Overview
The Mackay Institute of Research and Innovation (MIRI) is a Queensland based translational research and innovation centre. Our goal is to shape the future of the Mackay Hospital and Health Service (MHHS) by facilitating cutting-edge research and translation of scientific advances and new health knowledge into clinical practice. The MIRI innovation function provides expertise and support in various frameworks and rigorous methods of implementation science, but also extensive practical facilitation support for clinicians undertaking implementation projects through the MIRI Catalyst program. The Catalyst program provides direction over a suite of implementation projects with the aim of improving the quality and care provided to our communities. Catalyst will support clinicians with direction and capability development in the translation of research outcomes into improved health policy and practice, including health services evaluation to monitor the impact of implementation. Catalyst projects are focused on the organisation, funding and delivery of health services, with an emphasis on cost-effective analysis to deliver value for money in health systems. Although still in our infancy, having formed in 2017, The Cornerstone Program (Research Unit) have participated and continue to participate in Clinical Trials including Phase II and III trials, offering support to Clinicians who wish to contribute to Registries, University and Pharmacological Research as well as those wanting to undertake Investigator- Initiated Trials. Our clinical areas for potential research comprise of:
Anaesthesiology, Cardiovascular Oncology, Injuries and Accidents, Mental Health, Metabolic and Endocrine, Neurological, Oral and Gastrointestinal, Renal and Urogenital, Reproductive Health and Childbirth, Respiratory, Stroke, Orthopaedics, General Surgery
MIRI, as part of the Mackay Hospital and Health Service, provides support to 8 hospitals and four community health facilities. We are part of a contemporary organisation providing extensive health services in a range of regional, community and rural settings, to a population of around 180,000 people. Equipped with leading edge technology, the Mackay Base Hospital, where MIRI is situated, was the first fully digital public hospital with medications management in a regional area. As a member of the Tropical Australian Academic Health Centre (TAAHC), MIRI is also active in the new Teletrial concept developed between 4 HHSs covering rural and regional areas within Northern Queensland. This has given our community and hospital population the opportunity to participate in high quality clinical trials that would previously been outside of our area or would have seen them needing to travel great distances to be involved in.
Anaesthesiology, Cardiovascular Oncology, Injuries and Accidents, Mental Health, Metabolic and Endocrine, Neurological, Oral and Gastrointestinal, Renal and Urogenital, Reproductive Health and Childbirth, Respiratory, Stroke, Orthopaedics, General Surgery
MIRI, as part of the Mackay Hospital and Health Service, provides support to 8 hospitals and four community health facilities. We are part of a contemporary organisation providing extensive health services in a range of regional, community and rural settings, to a population of around 180,000 people. Equipped with leading edge technology, the Mackay Base Hospital, where MIRI is situated, was the first fully digital public hospital with medications management in a regional area. As a member of the Tropical Australian Academic Health Centre (TAAHC), MIRI is also active in the new Teletrial concept developed between 4 HHSs covering rural and regional areas within Northern Queensland. This has given our community and hospital population the opportunity to participate in high quality clinical trials that would previously been outside of our area or would have seen them needing to travel great distances to be involved in.
HREC
- HREC Committee Name: Townsville HHS HREC
- Meeting frequency: Monthly
- Types of HREC (IRB/ERB/ETHICS) Committee that are used: Central Acting as Local
- Mandate distribution of safety: Yes
- Meeting frequency: Monthly
- Types of HREC (IRB/ERB/ETHICS) Committee that are used: Central Acting as Local
- Mandate distribution of safety: Yes
Facility staffing and training
- Handling Investigational Product: Yes
- Training program for the research staff: Yes
- Include GCP: Yes
- Facility written sop during transportation to satellite site: Yes
- Training program for the research staff: Yes
- Include GCP: Yes
- Facility written sop during transportation to satellite site: Yes
Licenses to receive, store, dispense and return controlled substances
- Required Licenses or Registrations: Yes
- Does the Facility have the ability to handle radio-labelled Investigational Products? Yes
- Does the Facility have the ability to handle radio-labelled Investigational Products? Yes
Equipment
- Investigational Product: Horizontal laminar flow hood (non-hazardous drug preparation)
- Centrifuge: Yes
- Refrigerated Centrifuge: No
- Centrifuge: Yes
- Refrigerated Centrifuge: No
Patient Records
- Record Archiving: Yes
- EMR/EHR systems: In-house
- Has your Clinical Trial Site or Service been accredited? N/A
- Audit Type: N/A
- EMR/EHR systems: In-house
- Has your Clinical Trial Site or Service been accredited? N/A
- Audit Type: N/A
Investigational product storage Capabilities
- Refrigerator (2 to 8 Degrees C): Yes
- Freezer (-20 to -30 Degrees C): No
- Investigational Freezer (-70 to -80 Degrees C): No
- Investigational Freezer (Liquid Nitrogen -135 Degrees C): No
- Does this equipment have back-up power? Yes
- Does this equipment provide Min/Max Temperature Monitoring? Yes
- Do you have the ability to generate a temperature monitoring log for this equipment? Yes
- Does this equipment have a temperature alarm? Yes
- Do you have an SOP which supports calibration of this equipment? Yes
- Freezer (-20 to -30 Degrees C): No
- Investigational Freezer (-70 to -80 Degrees C): No
- Investigational Freezer (Liquid Nitrogen -135 Degrees C): No
- Does this equipment have back-up power? Yes
- Does this equipment provide Min/Max Temperature Monitoring? Yes
- Do you have the ability to generate a temperature monitoring log for this equipment? Yes
- Does this equipment have a temperature alarm? Yes
- Do you have an SOP which supports calibration of this equipment? Yes
Specialty Research Area
Acute Kidney Disease
Adult Coronary Syndrome
Anaemia
Angina
Aortic
Aplastic Anaemia
Arteriosclerosis
Atherosclerosis
Atrial Fibrillation
Atypical Haemolytic
Basal Cell Carcinoma
Benign Prostatic Hyperplasia
Bladder Cancer
Bone Cancer
Brain Cancer
Brain Ischemia
Breast Cancer
Cancer
Cardiovascular Diseases
Cervical Cancer
Chronic Heart Failure
Colorectal Cancer
Congestive Heart Failure
Coronary Artery Disease
Critical Care
Crohn's Disease
Cystitis
Dialysis
Digestive System Diseases
Diverticulitis
Endometriosis
Erectile Dysfunction
Febrile Neutropenia
Female Urogenital Diseases and Pregnancy Complications
Fertility
Follicular Lymphoma
Gastro Intestinal Solid Tumours
Gastro Oesophageal Refulx Disease (GERD)
Haemophilia
Head and Neck Cancer
Hepatocellular Carcinoma
Hereditary Angioedema
HR Prostate Cancer
Hypocalcaemia
Hypochlorhydria
Hypotension
Iron Deficiency Anaemia
Iron Overload
Irritable Bowel Syndrome
Ischemic Heart Disease
Islet Cell Tumours
Leukaemia
Leukopenia
Liver Cancer
Lung Cancer
Lymphoma
Malignant Pleural Mesothelioma
Melanoma
Mental Disorders
Mitral Valve Prolapse
Multiple Myeloma
NASH
Neoplasms
Neuroma
Non- Hodgkin's Lymphoma
Non-Small Cell Lung Cancer
NSCLC
Ovarian Epithelial Carcinoma
Overactive Bladder
Paediatrics
Pancreatic Cancer
Pancreatitis
Pericarditis
Peyronie's Disease
Phlebitis
Prostate Cancer
Refractory Anaemia
Renal Cell Carcinoma
Renal Failure
Sarcoma
Sickle Cell Anaemia
Soft Tissues Sarcomas
Solid tumours
Squamous & Non Squamous Sarcomas
Stroke
Throat Cancer
Thrombocytopenia
Thromboembolic Disease
Thyroid Cancer
Ulcerative Colitis
Upper GI Disorders
Uremic Syndrome
Urinary Tract Infection
Vascular Disease
Venous Thromboembolism
Wounds and Injuries
Study Types
Academic
Industry
Investigator
Source Document Types
Paper and Electronic
Average time to start study (in calendar days)
Greater than 120
Study Phase Capability
Phase III
Phase IV
Type of Diagnostic Equipment
CT Scan Computerized Tomography Scan
MRI Magnetic Resonance Imaging
X-Ray